Immunity status against poliomyelitis in Germany: Determination of cut-off values in International Units

被引:36
作者
Diedrich, S [1 ]
Claus, H [1 ]
Schreier, E [1 ]
机构
[1] Robert Koch Inst, D-13353 Berlin, Germany
关键词
D O I
10.1186/1471-2334-2-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background To prevent importations of wild polioviruses into a polio free region a high level of population immunity must be kept. Standard methodology for determination of polio antibodies is a feature aimed at obtaining consistent results. An International Standard Serum for polio antibodies exists, but no protective level in International Units is defined. Methods A representative study was carried out in order to determine the serological status against poliomyelitis in Germany (n= 2564, age 8 - 79 years). Furthermore, sera from persons aged less than 8 years were included ( n= 88). Microneutralization test has been used for determination of antibody levels. Results have been expressed in International Units. Results The results of this study indicate that the cut-off level for polio antibodies is 0.075 IU/ml for Polio, 0.80 IU/ml for Polio 2 and 0.080 IU/ml for Polio 3. Neutralizing antibodies against poliovirus type, 2 and 3 were detected in 96.2%, 96.8% and 89.6% of samples, respectively. Conclusions Overall, this seroprevalence indicates a very high level of immunity of the general population. It must be kept after the switch of immunization strategy from attenuated to inactivated vaccine in Germany.
引用
收藏
页数:10
相关论文
共 19 条
[1]  
Bellach B M, 1998, Gesundheitswesen, V60 Suppl 2, pS59
[2]   Immunity to poliomyelitis in the Netherlands [J].
Conyn-van Spaendonck, MAE ;
de Melker, HE ;
Abbink, F ;
Elzinga-Gholizadea, N ;
Kimman, TG ;
van Loon, T .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (03) :207-214
[3]   STATE OF IMMUNITY AGAINST POLIO IN GERMANY - POLIO SEROLOGY SURVEILLANCE 1993 [J].
DIEDRICH, S ;
SCHREIER, E .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (08) :239-244
[4]   Poliovirus Sabin type 1 neutralization epitopes recognized immunoglobulin A monoclonal antibodies [J].
Fiore, L ;
Ridolfi, B ;
Genovese, D ;
Buttinelli, G ;
Lucioli, S ;
Lahm, A ;
Ruggeri, FM .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6905-6912
[5]  
Franck S, 1999, ZBL BAKT-INT J MED M, V289, P475
[6]  
Juhela S, 1998, J MED VIROL, V54, P226, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt
[7]  
226::AID-JMV14&gt
[8]  
3.0.CO
[9]  
2-F
[10]   Immunity status against poliomyelitis in persons 13-14 years old living in Rome [J].
Mastroeni, I ;
Patti, AM ;
Fabrizi, A ;
Santi, AL ;
Manduca, AM ;
Vescia, N ;
Squarcione, S ;
Fara, GM .
VACCINE, 1997, 15 (6-7) :747-750